Nanostring nCounter® Open House - Sponsored by OUHSC Laboratory for Molecular
Biology and Cytometry Research - May 22nd, 10:00 am- 3:00pm, BRC103
Come hear about new technology offered in the OUHSC Core Facilities and enter for a chance to win $1,000 towards a new, Nanostring project.*
NanoString uses unique color-coded molecular barcodes that can directly hybridize to many different types of molecules, making it ideal for a range of discovery and translational research applications. The direct hybridization does not require amplification, library prep, or cDNA conversions. NanoString’s new 3D Biology™ technology enables multiplexed digital assays that provide a deeper view of biology through the analysis of multiple analytes: RNA, DNA, & proteins.
*Students, post docs and PIs must enter drawing at the event. Maximum of 2 winners from a single lab group. Please see attachment for additional information.
http://research.ouhsc.edu/Portals/1329/Assets/Documents/NanoString at OUHSC 22May2018.pdf?ver=2018-05-21-073131-713
The Office of Technology Development will offer the Innovation to Impact Series
“The Translational Research Journey.”
You will explore the differences between basic and translational research; learn about translational research funding through the Growth Fund and hear update from previous Growth Fund Recipients. This session will occur on May 23rd from Noon- 1:00 pm in Biomedical Research Center Building,
Room 103. Lunch will be provided. Please RSVP to firstname.lastname@example.org by May 18th. Space is limited to the first 15 attendees.
M2GEN Funding Opportunity Announcement for Team Science Award
M2Gen is inviting members of the Oncology Research Information Exchange (ORIEN) (the Stephenson Cancer Center is a member) to apply for the new ORIEN NOVA Awards for the purpose of:
1. Supporting the ORIEN mission through collaborative learning – Team Science.
2. Encouraging the ORIEN founding principle of data sharing and collaborative learning.
For additional information see attachments (3 handouts)
http://research.ouhsc.edu/Portals/1329/Assets/Documents/M2GEN ORIEN Member List as of 03-19-18.pdf?ver=2018-05-14-074542-173
http://research.ouhsc.edu/Portals/1329/Assets/Documents/M2GEN ORIEN NOVA Award Funding Opportunity Announcement April 2018 V12 FINAL.pdf?ver=2018-05-14-074542-313
http://research.ouhsc.edu/Portals/1329/Assets/Documents/M2GEN Release Notes 04-17-18 All Members.pdf?ver=2018-05-14-074542-377
OUHSC is soliciting nominees for the 2018 Pew Scholars Program in Biomedical Sciences Award. A single nominee will be selected from OUHSC. To be considered eligible, applicants must have a doctorate in biomedical sciences, medicine, or a related field and must be an assistant professor (modified title appointments are ineligible) and must have been appointed after June 29, 2015. Candidates interested in this program should submit a two-page research project summary, curriculum vitae, and letter of support from their department chair to the VPR’s office at VPR@ouhsc.edu. The deadline for submission is 5:00 PM, June 8, 2018. The selected candidate will be notified by June 29, 2018.
Shock Center Pilot Projects – The Oklahoma Nathan Shock Center is soliciting applications to support the research of junior investigators developing R01 applications and senior investigators developing new applications to the NIH in the Biology of Aging. All applications Due June 1, 2018. See attached document for additional details.
http://research.ouhsc.edu/Portals/1329/Assets/Documents/Shock Pilot Flyer 2018.pdf?ver=2018-05-21-073556-023
Save the Date - ORA Noon Conference
"Writing for Biomedical Publications" May 23, 2018 12pm-1pm, LIB299 (Auditorium)
Communicating the results of your research is an important part of the research enterprise. This talk will cover how to write original articles and provide tools necessary to successfully write, submit, and publish a manuscript. It will introduce the purpose of each section of a research article, describe the recommended approach, and provide information about common mistakes in writing or biomedical publications.
Additional Awards Eligible for PA-18-586 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) (NOT-OD-18-176)
National Center for Advancing Translational Sciences (NCATS) Policy for Support of Phase III
Clinical Trial Activities for a Rare Disease or Condition (NOT-TR-18-025)
Notice of Application Form Issue for RFA-HD-19-017, "National Centers for Translational Research in Reproduction and Infertility (P50)" (NOT-HD-18-011)
Notice of Change in Data Table Instructions for the PAR-18-746 NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) (NOT-DA-18-013)
Notice of Change to IND/IDE Authorization Timing Requirement for PAR-18-406 "Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)" (NOT-HL-18-625)
Notice of Change to IND/IDE Authorization Timing Requirement for PAR-18-407 "Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)" (NOT-HL-18-626)
Notice of Correction to Key Dates for PAR-17-450 "Limited Competition: Lasker Clinical Research Scholars Transition Award (R00)" (NOT-OD-18-177)
Notice of Expiration of PA-18-473 "Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed)" (NOT-NR-18-010)
Notice of NIMHD's Interest in the Health of Puerto Rican and US Virgin Island Residents Migrating to the US Mainland after Hurricanes Irma and Maria (NOT-MD-18-005)
Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2018 (NOT-OD-18-175)
Transition from Inclusion Management System to New Human Subjects System (HSS) as of June 9, 2018 (NOT-OD-18-179)
Update in Funds Application Due Date(s) & Expiration Date Sections of RFA-FD-08-010 Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations (U01) (NOT-FD-18-011)
Please Note: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least one month prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
Collaborative Activities to Expedite Environmental Health Science Research, Translation, and Community Engagement Across EHS Core Centers (Admin Supp - Clinical Trial Not Allowed) (PA-18-77) – Deadline June 7, 2018
Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed) (PAR-18-781) – Deadline September 4, 2018
Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34 - Clinical Trial Optional) (PA-18-780) – Deadline June 16, 2018
International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional) (PA-18-773) – October 5, 2018
Investigation of the Transmission of Kaposi Sarcoma-associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) (RFA-CA-18-013) – Deadline August 16, 2018. https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-013.html
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R21 Clinical Trial Not Allowed) (RFA-CA-18-014) – Deadline August 16, 2018. https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-014.html
Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional) (PA-18-776) – Deadline October 5, 2018. https://grants.nih.gov/grants/guide/pa-files/PA-18-776.html
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) (PAR-18-771) – Deadline June 12 and October 12, 2018. https://grants.nih.gov/grants/guide/pa-files/PAR-18-771.html
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) (PAR18-772) – Deadline June 12 and October 12, 2018. https://grants.nih.gov/grants/guide/pa-files/PAR-18-772.html
NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed) (PAR-18-782) Deadline August 27, 2018.
NIOSH Occupational Safety and Health Research (R01) (PAR-18-769) – Deadline July 6, 2018.
Novel Genomic Technology Development (R01 Clinical Trial Not Allowed) (PAR-18-777) Deadline October 2, 2018.
Novel Genomic Technology Development (R21 Clinical Trial Not Allowed) (PAR-18-778) Deadline October 2, 2018.
Novel Genomic Technology Development (R43/R44 Clinical Trial Not Allowed) (PAR-18-779) Deadline October 2, 2018.
Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional) (PA-18-775) – Deadline June 16, 2018
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) (PA-18-774) – Deadline June 16, 2018. https://grants.nih.gov/grants/guide/pa-files/PA-18-774.html
Research Program Award (R35 Clinical Trial Optional) (RFA-NS-18-032) – Deadline July 13, 2018.
Understanding Skeletal Effects of Type 1 Diabetes (R01 Clinical Trial Optional) (RFA-DK-18-002) Deadline December 6, 2018.
OTHER FEDERAL DEADLINES
Department of Defense (DOD) – Tuberous Sclerosis Complex Research Program – Idea Development Award – Required Pre-Application Deadline is July 11, 2018 and Application. Deadline is August 2, 2018. http://cdmrp.army.mil/funding/tscrp
DOD – Tuberous Sclerosis Complex Research Program – Exploration Hypothesis Development Award – Required Pre-Application Deadline is July 11, 2018 and Application Deadline is August 2, 2018. http://cdmrp.army.mil/funding/tscrp
DOD – Tuberous Sclerosis Complex Research Program – Clinical Translational Research Award - Required Pre-Application Deadline is July 11, 2018 and Application Deadline is August 2, 2018. http://cdmrp.army.mil/funding/tscrp
DOD – Tuberous Sclerosis Complex Research Program – Clinical Trial Award – Required Pre-Application Deadline is July 26, 2018 and Application Deadline is August 9, 2018. http://cdmrp.army.mil/funding/nfrp
DOD – Tuberous Sclerosis Complex Research Program – Exploration Hypothesis Development Award – Required Pre-Application Deadline is July 26, 2018 and Application Deadline is August 9, 2018. http://cdmrp.army.mil/funding/nfrp
DOD – Tuberous Sclerosis Complex Research Program – Investigator Initiated Research Award - Required Pre-Application Deadline is July 26, 2018 and Application Deadline is August 9, 2018. http://cdmrp.army.mil/funding/nfrp
DOD – Tuberous Sclerosis Complex Research Program – New Investigator Award – Required Pre-Application Deadline is July 26, 2018 and Application Deadline is August 9, 2018. http://cdmrp.army.mil/funding/nfrp
DOD – Tuberous Sclerosis Complex Research Program – Early Investigator Research Award - Required Pre-Application Deadline is July 26, 2018 and Application Deadline is August 14, 2018. http://cdmrp.army.mil/funding/nfrp
Robert Wood Johnson Foundation (RWJF) – Evidence for Action: Making Health Shared Value. Deadline June 1, 2018.
RWJF – Policies for Acton: Policy and Law Research to Build a Culture of Health. Deadline June 7, 2018.
RWJF – RWJF Sports Award 2018 – Deadline July 2, 2018.
RWJF – Evidence for Action: Investigator-Initiated Research to Build a Culture of Health. Deadline OPEN.